Navigation Links
Drugs Derived from Kratom & Cannabis focus on New Organic Market Research Study for Pain Medicine Solutions

COLORADO SPRINGS, CO, March 29, 2017 /PRNewswire/ - Last year's petition to the White House signed by 120,000 people who support kratom are not the only efforts active to generate awareness on the importance of new organic medicines and nutritional products that substitute opiate based pharmaceutical drugs in the healthcare market place.

Earlier this month Health Advance (OTC PINK: HADV), a U.S. based developer and distributor of pharmaceutical and nutritional products, announced its endeavors on this generally recognized as safe (also known as GRAS) by the US Food and Drug Administration (FDA) product development of medical foods containing ibuprofen and botanical extract blends derived from mitragyna speciosa, kava, and cannabidiol to treat pain and severe illness.

The company's patent-pending product formulations for cebidiofen and polyoxfen gained a special interest among 81% of the pain medicine physicians that participated in the market research study, opposed to the 19% who thought that there were not better alternatives for opium derivatives like oxycodone, hydrocodone, buprenorphine, oxymorphone, and hydromorphone.

Health Advance is the first bio-tech company in three years to announce its medical product development program and clinical testing of medicinal solutions that interacts with kratom since Sigma-Aldrich Corp, who were acquired by Merck KGaA for $17 billion in 2014. 

Green Health's market research survey on organic pain medicine alternatives to synthetic opiate drugs is the first step to building awareness for new organic medicines like cebiodiofen and polyoxfen that will hopefully be on the GRAS list with the Food and Drug Administration before the end of this year.

Green Health Advocates has created a presence on social media and news blogs with over 500,000 followers to provide research updates and product information on organic medicine and dietary supplements to potential consumers and investors. 


#organic medicine, #dietary supplements #consumers, #investors, #gwpharm, #cannabidiol, #kratom, #mitragyna speciosa, #kava, #oxycodone, #hydrocodone, #buprenorphine, #oxymorphone, #hydromorphone, #ibuprofen, #botanical extracts

SOURCE Green Health Advocates
Copyright©2017 PR Newswire.
All rights reserved

Related biology technology :

1. Alzheimer Disease - New Drugs, Markets and Companies - 2013
2. Currently approved drugs found effective in laboratory mice against bioterror threats
3. Stem Cells Might Beat Drugs in Delivering Relief Faster, More Effectively to Rheumatoid Arthritis Sufferers
4. Neuroprotection - Drugs, Markets and Companies - Updated 2013 Report with Extra Company Collaborations
5. Spartan Bioscience Receives FDA Clearance for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs
6. Legislative Benefits and Unmet Needs to Drive the Market for Orphan Drugs, According to a New Report by Global Industry Analysts, Inc.
7. In The Face Of Increasing Healthcare Spend And High-Cost Targeted Treatment, Market Access Barriers Continue To Rise For Targeted Oncology Drugs
8. Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer
9. Tricking algaes biological clock boosts production of drugs, biofuels
10. Biohack Pure’s Jonathan Weisman Predicts the Future of Smart Drugs
11. Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs
Post Your Comments:
(Date:8/29/2019)... , ... August 28, 2019 , ... ... wide-ranging DuPont™ Danisco® ingredient solutions to attendees at the International Baking Industry Expo, ... today’s baking challenges from optimizing production efficiency to cost and waste reduction and ...
(Date:8/27/2019)... ... 27, 2019 , ... Dr. Kim Carlson is a veterinary surgeon practicing in ... Surgical Group , a new surgical practice in San Mateo. She is currently ... more veterinary specialists as the practice grows. , When asked about the opening of ...
(Date:8/25/2019)... ... August 23, 2019 , ... Authors ... status for the scientific research book “Impact of Biofield Treatment on Growth and ... industry as Patchouli. , The book garnered No. 1 status on Amazon ...
(Date:8/23/2019)... ... August 22, 2019 , ... An upcoming episode of Advancements ... broadcast 4Q/2019. Check your local listings for more information. , This segment will ... Focusing on therapeutics for children and the elderly, viewers will learn about Avro’s ...
Breaking Biology Technology:
(Date:8/29/2019)... ... August 28, 2019 , ... ... Clinical Research Organization), have recently passed their five-year milestone of collaboration in ... psychoneuroendocrine stress expertise, with a primary focus towards performing feasibility studies, phase ...
(Date:8/27/2019)... ... August 27, 2019 , ... Ambry Genetics ... improve genetic testing guidelines. In the largest cohort study of its kind, Ambry ... at-risk patients. , Clinicians use guidelines to inform decisions about which patients ...
(Date:8/25/2019)... , ... August 23, 2019 , ... ... of a new qualitative research solution: Experts-on-Demand. The service helps connect companies with ... consultations. , “The pace of science, technology, and medicine is moving faster than ...
Breaking Biology News(10 mins):